Increased Serum Levels of Tumor Necrosis Factor a ! Precede Major Complications of Bone Marrow Transplantation

Acute graft-versus-host disease, interstitial pneumonitis, endothelial leakage syndrome, and veno-occlusive disease are major complications of bone marrow transplantation. Though several new regimens for prophylaxis and treatment of these syndromes have been introduced, the overall incidence has been only slightly reduced over the last few years. We retrospectively analyzed tumor necrosis factor alpha (TNFa) serum levels between day -8 and day 100 after bone marrow transplantation in 56 patients transplanted in our unit for a variety of hematological diseases. In 34 patients with uneventful courses, mean TNFa levels rose to a maximum of 76 k 29 pg/mL. In contrast, 22 patients with major transplant related complications showed

[1]  E. Nilsson,et al.  Isolation and characterization of a tumor necrosis factor binding protein from urine , 1989, European journal of haematology.

[2]  J. Larrick Native interleukin 1 inhibitors. , 1989, Immunology today.

[3]  E. Girardin,et al.  Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. , 1988, The New England journal of medicine.

[4]  Richard B. Johnston Current concepts: immunology. Monocytes and macrophages. , 1988, The New England journal of medicine.

[5]  S. Rosenberg,et al.  Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome. , 1988, Journal of immunology.

[6]  J. Tavernier,et al.  EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCER , 1987, The Lancet.

[7]  C. Maury,et al.  Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection , 1987, The Journal of experimental medicine.

[8]  P. Scuderi,et al.  RAISED SERUM LEVELS OF TUMOUR NECROSIS FACTOR IN PARASITIC INFECTIONS , 1986, The Lancet.

[9]  A. Rimm,et al.  Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. , 1986, Annals of internal medicine.

[10]  R. Storb,et al.  Graft‐versus‐Host Disease in Dog and Man: The Seattle Experience , 1985, Immunological reviews.

[11]  C. Perreault,et al.  Persistence of host Langerhans cells following allogeneic bone marrow transplantation: possible relationship with acute graft‐versus‐host disease , 1985, British journal of haematology.

[12]  R. Powles,et al.  Mismatched family bone marrow transplantation. , 1984, Seminars in hematology.

[13]  D. Golde,et al.  Direct evidence for a bone marrow origin of the alveolar macrophage in man. , 1976, Science.

[14]  V. Srinivasan,et al.  Veno occlusive disease. , 1998, Tropical gastroenterology : official journal of the Digestive Diseases Foundation.

[15]  D. A. Flick,et al.  Natural production and release of tumour necrosis factor. , 1987, Ciba Foundation symposium.